Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hawk Kim
Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation From Unrelated or Haploidentical Family Donors in Patients With Acute Myeloid Leukemia in Remission
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity
PLoS ONE
Multidisciplinary
Related publications
Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin
Neoplasma
Cancer Research
Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia
Cancer Control
Medicine
Oncology
Hematology
Reduced-Intensity Conditioning Using Fludarabine With Either Antithymocyte Globulin and BU, or Low-Dose TBI Allowing Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Thiotepa, Busulfan and Fludarabine Compared to Busulfan and Cyclophosphamide as Conditioning Regimen for Allogeneic Stem Cell Transplant From Matched Siblings and Unrelated Donors for Acute Myeloid Leukemia
American Journal of Hematology
Hematology
Hematopoietic Transplantation From Adult Unrelated Donors as Treatment for Acute Myeloid Leukemia
Bone Marrow Transplantation
Transplantation
Hematology
Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: Comparable Outcomes With Unrelated Umbilical Cord Blood and HLA-Identical Sibling Donors
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Haploidentical vs Autologous Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia Beyond First Remission
Bone Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab From HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients With Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Fludarabine-Based Dose-Reduced Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation From Related or Unrelated Donors in Patients With Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
